Literature DB >> 26988048

Whole-Genome Sequences of Two Campylobacter coli Isolates from the Antimicrobial Resistance Monitoring Program in Colombia.

Johan F Bernal1, Pilar Donado-Godoy1, María Fernanda Valencia1, Maribel León2, Yolanda Gómez1, Fernando Rodríguez1, Richa Agarwala3, David Landsman3, Leonardo Mariño-Ramírez4.   

Abstract

Campylobacter coli, along with Campylobacter jejuni, is a major agent of gastroenteritis and acute enterocolitis in humans. We report the whole-genome sequences of two multidrug-resistance C. coli strains, isolated from the Colombian poultry chain. The isolates contain a variety of antimicrobial resistance genes for aminoglycosides, lincosamides, fluoroquinolones, and tetracycline.
Copyright © 2016 Bernal et al.

Entities:  

Year:  2016        PMID: 26988048      PMCID: PMC4796127          DOI: 10.1128/genomeA.00131-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Campylobacter spp. are microaerobic, non-spore-forming, Gram-negative, and oxidase-positive members of the Campylobacteraceae family (1). Campylobacter spp. are zoonotic pathogens (2) and some of the main bacteria associated with human food-borne illness (3, 4). Campylobacteriosis is frequently associated with the consumption of undercooked poultry meat and the mishandling of the raw poultry products (5, 6). Different Campylobacter spp. are recognized as causing human gastroenteritis worldwide (7–9). Campylobacter coli is commonly isolated from swine and less so from poultry and humans (7, 9). Although C. coli accounts for fewer infections in humans than Campylobacter jejuni, its impact is considerable (10), taking into account the increased capability for antimicrobial resistance (11), where multidrug efflux pumps play an important role as mechanisms of antibiotic resistance (3). A small number of studies in Colombia have focused on understanding the epidemiology of Campylobacter spp. and their associated antimicrobial resistance. To correct this deficiency, the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS) (12, 13) has been included in the Colombia-wide Campylobacter surveillance program, whose priority is to generate information for different governmental institutions, agricultural enterprises, and food animal production systems. The findings from our studies in Colombia have shown that C. coli and C. jejuni contamination of raw poultry and poultry meat products present risk factors associated with acute illness in consumers of these products. Here, we present the whole-genome sequences of two multidrug-resistant C. coli strains (M1483 and M1486), isolated from poultry meat collected from two retail stores in Bogotá, Colombia, as part of the COIPARS antimicrobial resistance monitoring program. Genomic DNA was isolated from overnight cultures using the PureLink Genomic DNA minikit (Invitrogen, Grand Island, NY, USA), and DNA libraries were prepared using SureSelect QXT sample preparation kit (Agilent, Santa Clara, CA, USA). The libraries were prepared according to the manufacturer’s instructions and sequenced on an Illumina HiScanSQ instrument with 1 × 151-bp single reads, according to standard Illumina protocols. The C. coli M1483 and M1486 genomes were assembled using the reference-guided assembler ARGO, developed at NCBI, and the de novo assembler SPAdes (14). The genome sequence of strains M1483 and M1486 consisted of 45 and 55 contigs, yielding total sequences of 1,683,490 bp and 1,780,967 bp, respectively. The overall G+C content of the isolates was determined to be 32%. Sequences were annotated using the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) and have been deposited in GenBank. The results of the genome annotation presenting the number of genes, coding sequences, pseudogenes, CRISPR arrays, rRNAs, tRNAs, and noncoding RNAs are summarized in Table 1.
TABLE 1 

Campylobacter coli genome annotation statistics

StrainNCBI BioSampleNo. of genesNo. of CDSsaNo. of pseudogenesNo. of CRISPR arraysNo. of rRNAsNo. of tRNAsNo. of ncRNAsbGenBank accession no.
M1483SAMN043580931,7821,7395503373LQXL00000000
M1486SAMN043580911,9161,8735813373LQXK00000000

CDSs, coding sequences.

ncRNAs, noncoding RNAs.

Campylobacter coli genome annotation statistics CDSs, coding sequences. ncRNAs, noncoding RNAs. A search for resistance-associated genes present in the isolates was performed using ResFinder version 2.1 (15) and enriched using RAST version 2.0 (16), both with default parameters. We found antimicrobial resistance genes for aminoglycosides (Aph 3′-III), lincosamides (InuC), fluoroquinolones (gyrA and gyrB), and tetracyclines (EF-G and TetO). Additionally, we found efflux pump genes (CmeA, CmeB, TolC, MATE, MFS, MacA, MacB, RND, AcrB, and OM) and CmeABCR operon genes, both associated with increased multidrug resistance.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited in DDBJ/EMBL/GenBank under the accession numbers listed in Table 1. The versions described in this paper are the second versions.
  16 in total

1.  Comparative characterization of the virulence gene clusters (lipooligosaccharide [LOS] and capsular polysaccharide [CPS]) for Campylobacter coli, Campylobacter jejuni subsp. jejuni and related Campylobacter species.

Authors:  Vincent P Richards; Tristan Lefébure; Paulina D Pavinski Bitar; Michael J Stanhope
Journal:  Infect Genet Evol       Date:  2012-12-29       Impact factor: 3.342

2.  Effects of efflux-pump inducers and genetic variation of the multidrug transporter cmeB in biocide resistance of Campylobacter jejuni and Campylobacter coli.

Authors:  Ana Mavri; Sonja Smole Možina
Journal:  J Med Microbiol       Date:  2012-11-15       Impact factor: 2.472

Review 3.  Campylobacteriosis: the role of poultry meat.

Authors:  C P A Skarp; M-L Hänninen; H I K Rautelin
Journal:  Clin Microbiol Infect       Date:  2015-12-11       Impact factor: 8.067

Review 4.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

5.  Evidence for phenotypic plasticity among multihost Campylobacter jejuni and C. coli lineages, obtained using ribosomal multilocus sequence typing and Raman spectroscopy.

Authors:  Daniel S Read; Dan J Woodcock; Norval J C Strachan; Kenneth J Forbes; Frances M Colles; Martin C J Maiden; Felicity Clifton-Hadley; Anne Ridley; Ana Vidal; John Rodgers; Andrew S Whiteley; Samuel K Sheppard
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

6.  Tracking Campylobacter contamination along a broiler chicken production chain from the farm level to retail in China.

Authors:  Licai Ma; Yang Wang; Jianzhong Shen; Qijing Zhang; Congming Wu
Journal:  Int J Food Microbiol       Date:  2014-04-28       Impact factor: 5.277

7.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

8.  Comparison of Antimicrobial Susceptibility of Campylobacter Strains Isolated from Food Samples and Patients with Diarrhea.

Authors:  Bita Bakhshi; Amin Naseri; Masoud Alebouyeh
Journal:  Iran Biomed J       Date:  2015-11-25

9.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

Review 10.  Antimicrobial resistance mechanisms among Campylobacter.

Authors:  Kinga Wieczorek; Jacek Osek
Journal:  Biomed Res Int       Date:  2013-06-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.